Esperoct

turoctocog alfa pegol · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Esperoct, covering 2024-10-31 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®